Nutritional Considerations With the GLP-1 Medications

Description

The use of GLP-1 receptor agonists for obesity and metabolic disease management has risen rapidly, creating a new set of nutritional and functional challenges. While effective for weight loss, these medications can contribute to reduced appetite, nutrient deficiencies, lean mass loss, and gastrointestinal symptoms.

This webinar will equip health professionals in supporting clients using GLP-1s. Practitioners will examine the medications’ physiological effects, nutritional risks, and clinical strategies for symptom relief and muscle preservation. Practitioners will also gain the tools to address client factors such as energy levels, muscle integrity, and hydration.

Instructors

Learning Objectives

● Analyze the benefits and risks of the GLP-1 medications in weight management

● Evaluate the nutritional implications of GLP-1 use, including risks of deficiencies that may impair participation in daily activities

● Integrate evidence-informed dietary strategies to minimize symptoms and support client engagement in meaningful occupations

● Design client-centered recommendations that combine nutrition and exercise to preserve lean mass and support performance across occupations

Agenda

All times in Eastern Time.

6:00pm–6:15pm

The Physical and Physiological Impact of Anti-obesity Medications

6:15pm–6:30pm

Nutritional Insufficiencies and Deficiencies

6:30pm–6:45pm

Nutritional Strategies for Symptom Relief and Management

6:45pm–7:00pm

Minimizing Lean Mass Loss and Maximizing Muscle Preservation

7:00pm–7:05pm

Break

6:07pm–7:35pm

Q&A Session

---

Medbridge is committed to accessibility for all of our subscribers. If you are in need of a disability-related accommodation, please contact [email protected] . We will process requests for reasonable accommodation and will provide reasonable accommodations where appropriate, in a prompt and efficient manner.